The IC 50 values for GDC were determined using non-linear regression analysis
Red Wine Consumption and Cardiovascular Health
After 46 weeks of treatment: 0.6 mg dose: 6.2% mean body weight reduction 2.4 mg dose: 12.5% mean body weight reduction 3.6 mg dose: 13.2% mean body weight reduction 4.8 mg dose: 14.9% mean body weight reduction (all randomized) 4.8 mg dose: 18.7% mean body weight reduction (completers only) Placebo: 2.8% mean body weight reduction Among completers at the 4.8 mg dose, 68.8% achieved at least 10% weight loss, 67% achieved at least 15%, and 40% achieved at least 20% weight loss
HPLC testing verifies a purity level of 98%, ensuring reliable and reproducible research outcomes
doi: 10.3389/fphar.2024.1493188 Received 08 September 2024 Accepted 12 November 2024 Published 10 January 2025 Volume 15 - 2024 Edited by Xuelin Zhou, Capital Medical University, China Reviewed by Nianping Liu, Stanford University, United States Chenxu Guo, Massachusetts General Hospital Cancer Center, United States Xiaoyan Tang, University of California, San Francisco, United States Updates Copyright 2025 Imam, Ji, Zhang and Yan
We're cool, right
